- Conditions
- Rectal Health, Rectal Behaviors, Anorectal Symptomatology
- Interventions
- Not listed
- Lead sponsor
- University of California, Los Angeles
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 896 participants
- Timeline
- Started 2006
- U.S. locations
- 2
- States / cities
- Los Angeles, California • Baltimore, Maryland
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–13
of 13
matching trials from the live ClinicalTrials.gov search.
- Conditions
- HIV Infections
- Interventions
- Nonoxynol-9
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 70 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- Ends 1999
- U.S. locations
- 1
- States / cities
- Seattle, Washington
- Conditions
- Rectal Microbicides
- Interventions
- Tenofovir 1% gel, 2% N-9 gel, HEC Placebo gel
- Drug
- Lead sponsor
- CONRAD
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 65 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2011
- U.S. locations
- 3
- States / cities
- Birmingham, Alabama • Boston, Massachusetts • Pittsburgh, Pennsylvania
- Conditions
- HIV Infections
- Interventions
- UC-781 microbicide gel (0.1% and 0.25%), placebo
- Drug
- Lead sponsor
- University of California, Los Angeles
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 36 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2008
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Microbicide Delivery System Perceptibility and Acceptability
- Interventions
- Gel, Cream, Liquid
- Other
- Lead sponsor
- The Miriam Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 18 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2022
- U.S. locations
- 1
- States / cities
- Providence, Rhode Island
- Conditions
- HIV Infections
- Interventions
- Normosol-R, Nonoxynol-9, Gastrointestinal instrumentation
- Drug · Procedure
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 21 Years and older · Male only
- Enrollment
- 12 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2009
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Microbicide Delivery System Perceptibility and Acceptability
- Interventions
- Gel, Suppository 1, Suppository 2
- Other
- Lead sponsor
- The Miriam Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 32 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2022
- U.S. locations
- 1
- States / cities
- Providence, Rhode Island
- Conditions
- HIV Prevention
- Interventions
- Placebo rectal insert, Placebo rectal suppository, Placebo rectal douche
- Behavioral
- Lead sponsor
- Microbicide Trials Network
- Network
- Eligibility
- 18 Years to 35 Years
- Enrollment
- 217 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 3
- States / cities
- Birmingham, Alabama • San Francisco, California • Pittsburgh, Pennsylvania
- Conditions
- HIV Prevention
- Interventions
- Once Daily Application of TFV RG 1% Gel - Vaginal, Once Daily Application of TFV RG 1% gel - Rectal
- Drug
- Lead sponsor
- CONRAD
- Other
- Eligibility
- 21 Years to 45 Years · Female only
- Enrollment
- 14 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- HIV Infections, HIV Seronegativity
- Interventions
- Flexible Sigmoidoscopy, Rectal Biopsy
- Procedure
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 16 participants
- Healthy volunteers
- Accepts healthy volunteers
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- HIV Prevention, HIV Infections
- Interventions
- Tenofovir, HEC Placebo, Open label tenofovir tablet
- Drug
- Lead sponsor
- CONRAD
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 18 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2010
- U.S. locations
- 2
- States / cities
- Los Angeles, California • Pittsburgh, Pennsylvania
- Conditions
- HIV Prevention
- Interventions
- Rectal formulation (RF) of tenofovir 1% gel, Vaginal formulation (VF) of tenofovir 1% gel, Reduced glycerin vaginal formulation (RGVF) of tenofovir 1% gel, Radiolabeling of study drugs and semen
- Drug · Radiation
- Lead sponsor
- Ian McGowan
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 9 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- HIV Prevention
- Interventions
- Q-Griffithsin (Q-GRFT) enema, Placebo enema
- Drug · Other
- Lead sponsor
- Rhonda Brand
- Other
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 18 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2021
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania